Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients

Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients

COVID-19 convalescent plasma (CCP) has been the only specific anti-viral therapy against SARS-CoV-2 available for more than one year. Following the negative results from most randomized controlled trials on its efficacy in COVID-19 hospitalized patients and the availability of anti-spike monoclonal...

Full description

Bibliographic Details
Main Authors: Massimo Franchini, Daniele Focosi, Elena Percivalle, Massimiliano Beccaria, Martina Garuti, Omar Arar, Antonietta Pecoriello, Fabio Spreafico, Graziana Greco, Stefano Bertacco, Marco Ghirardini, Tiziana Santini, Michele Schiavulli, Muzzica Stefania, Thaililja Gagliardo, Josè Camilla Sammartino, Alessandro Ferrari, Matteo Zani, Alessia Ballotari, Claudia Glingani, Fausto Baldanti
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Viruses
Subjects:
COVID-19 convalescent plasma
SARS-CoV-2
variants of concern
efficacy
Online Access:https://www.mdpi.com/1999-4915/14/7/1443

Internet

https://www.mdpi.com/1999-4915/14/7/1443

Similar Items